SMTL ID : 1nhg.2 (1 other biounit)

CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL-ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

hetero-4-4-mer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 26 residues within 4Å: Chain A: G.8, I.9, G.10, G.14, Y.15, W.35, F.71, D.72, A.73, S.74, S.119, L.120, A.121, N.122, L.169, T.170, Y.171, K.189, A.216, G.217, P.218, L.219, S.221, A.223 Chain C: I.4 Ligands: TCL.2 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:Y.15, A:Y.171, A:A.216 Hydrogen bonds: A:Y.15, A:D.72, A:A.73, A:S.74, A:L.120, A:A.121, A:K.189, A:L.219, A:L.219, A:S.221, A:S.221, A:A.223 pi-Stacking: A:W.35, A:W.35, A:W.35 NAD.3: 25 residues within 4Å: Chain B: I.9, G.10, G.14, Y.15, W.35, F.71, D.72, A.73, S.74, S.119, L.120, A.121, N.122, L.169, T.170, Y.171, K.189, A.216, G.217, P.218, L.219, S.221, A.223 Chain D: I.4 Ligands: TCL.4 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:Y.15, B:Y.171, B:A.216 Hydrogen bonds: B:Y.15, B:D.72, B:A.73, B:S.74, B:L.120, B:K.189, B:L.219, B:L.219, B:S.221, B:S.221, B:A.223 pi-Stacking: B:W.35, B:W.35, B:W.35 NAD.5: 26 residues within 4Å: Chain E: G.8, I.9, G.10, G.14, Y.15, W.35, F.71, D.72, A.73, S.74, S.119, L.120, A.121, N.122, L.169, T.170, Y.171, K.189, A.216, G.217, P.218, L.219, S.221, A.223 Chain G: I.4 Ligands: TCL.6 18 PLIP interactions: 18 interactions with chain E Hydrophobic interactions: E:Y.15, E:Y.171, E:A.216 Hydrogen bonds: E:Y.15, E:D.72, E:A.73, E:S.74, E:L.120, E:A.121, E:K.189, E:L.219, E:L.219, E:S.221, E:S.221, E:A.223 pi-Stacking: E:W.35, E:W.35, E:W.35 NAD.7: 25 residues within 4Å: Chain F: I.9, G.10, G.14, Y.15, W.35, F.71, D.72, A.73, S.74, S.119, L.120, A.121, N.122, L.169, T.170, Y.171, K.189, A.216, G.217, P.218, L.219, S.221, A.223 Chain H: I.4 Ligands: TCL.8 18 PLIP interactions: 18 interactions with chain F Hydrophobic interactions: F:Y.15, F:Y.171, F:A.216 Hydrogen bonds: F:Y.15, F:D.72, F:D.72, F:A.73, F:S.74, F:L.120, F:K.189, F:L.219, F:L.219, F:S.221, F:S.221, F:A.223 pi-Stacking: F:W.35, F:W.35, F:W.35

4 x TCL: TRICLOSAN(Non-covalent)

TCL.2: 11 residues within 4Å: Chain A: A.121, N.122, A.123, Y.171, Y.181, K.189, A.223, A.224, I.227 Chain C: F.3 Ligands: NAD.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.121, A:Y.171, A:Y.181, A:A.223, A:A.224, A:I.227 Hydrogen bonds: A:Y.181 pi-Stacking: A:Y.171 Halogen bonds: A:A.123 TCL.4: 12 residues within 4Å: Chain B: A.121, N.122, A.123, V.126, Y.171, Y.181, K.189, A.223, A.224, I.227 Chain D: F.3 Ligands: NAD.3 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:V.126, B:Y.171, B:Y.181, B:I.227 Hydrogen bonds: B:Y.181 pi-Stacking: B:Y.171 Halogen bonds: B:A.123 TCL.6: 11 residues within 4Å: Chain E: A.121, N.122, A.123, Y.171, Y.181, K.189, A.223, A.224, I.227 Chain G: F.3 Ligands: NAD.5 10 PLIP interactions: 10 interactions with chain E Hydrophobic interactions: E:A.121, E:Y.171, E:Y.181, E:A.223, E:A.224, E:I.227 Hydrogen bonds: E:Y.181, E:Y.181 pi-Stacking: E:Y.171 Halogen bonds: E:A.123 TCL.8: 12 residues within 4Å: Chain F: A.121, N.122, A.123, V.126, Y.171, Y.181, K.189, A.223, A.224, I.227 Chain H: F.3 Ligands: NAD.7 8 PLIP interactions: 8 interactions with chain F Hydrophobic interactions: F:V.126, F:Y.171, F:Y.181, F:I.227 Hydrogen bonds: F:Y.181, F:Y.181 pi-Stacking: F:Y.171 Halogen bonds: F:A.123

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Perozzo, R. et al., Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan forMalarial Enoyl Acyl Carrier Protein Reductase. J.Biol.Chem. (2002)

Release Date

2003-02-25

Peptides

enoyl-acyl carrier reductase: ABEF
enoyl-acyl carrier reductase: CDGH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

E
A

F
B

C
C

D
D

G
C

H
D

enoyl-acyl carrier reductase

enoyl-acyl carrier reductase

Related Entries With Identical Sequence